Literature DB >> 21938495

Comparison of treatment results between surgery alone, preoperative short-course radiotherapy, or long-course concurrent chemoradiotherapy in locally advanced rectal cancer.

Chung-Hung Yeh1, Miao-Fen Chen, Chia-Hsuan Lai, Wen-Shih Huang, Steve P Lee, Wen-Cheng Chen.   

Abstract

BACKGROUND: The aim of this study is to compare the results between surgery alone, preoperative radiotherapy (RT), or preoperative concurrent chemoradiotherapy (CCRT) followed by surgery in the treatment of locally advanced rectal cancer in Asian patients.
METHODS: This study included 151 consecutive patients with clinical T3, T4 or node-positive rectal cancer from Jan. 2005 to Dec. 2007. Eighty-six patients underwent total mesorectal excision (TME) alone, 28 patients received preoperative RT (25 Gy in 5 fractions) followed by TME in 1 week, and 37 patients received preoperative CCRT (50.4 Gy in 28 fractions) followed by TME in 4-6 weeks.
RESULTS: The 3-year loco-regional recurrence (LRR), distant metastasis, overall and disease-free survival rates are comparable among Surgery, RT and CCRT groups. By multivariate analysis, pT4, distal margin <2 cm, the ratio of positive lymph nodes to totally dissected lymph nodes ≥ 0.2, and non-R0 resection were significant factors for LRR. In subgroup analysis, TME alone produced comparable LRR to RT or CCRT (3.3 vs.. 4.8%) for favorable patients (0-1 risk factors). For unfavorable patients (2 or more risk factors), the LRR rose to 37% in patients receiving surgery alone as compared with 15% in the RT or CCRT patients.
CONCLUSIONS: Preoperative RT or CCRT followed by TME produced good local control in favorable and unfavorable patients with locally advanced rectal cancer. If preoperative RT or CCRT is not given, TME alone has a high incidence of local recurrence in unfavorable patients with 2 or more risk factors.

Entities:  

Mesh:

Year:  2011        PMID: 21938495     DOI: 10.1007/s10147-011-0317-0

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  36 in total

1.  Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer.

Authors:  E Kapiteijn; C A Marijnen; I D Nagtegaal; H Putter; W H Steup; T Wiggers; H J Rutten; L Pahlman; B Glimelius; J H van Krieken; J W Leer; C J van de Velde
Journal:  N Engl J Med       Date:  2001-08-30       Impact factor: 91.245

2.  Improved survival with preoperative radiotherapy in resectable rectal cancer.

Authors:  B Cedermark; M Dahlberg; B Glimelius; L Påhlman; L E Rutqvist; N Wilking
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

3.  Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Stockholm Rectal Cancer Study Group.

Authors: 
Journal:  Cancer       Date:  1990-07-01       Impact factor: 6.860

4.  A new approach to rectal cancer.

Authors:  R J Heald
Journal:  Br J Hosp Med       Date:  1979-09

5.  Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy.

Authors:  Morten T Eriksen; Arne Wibe; Jon Haffner; Johan N Wiig
Journal:  Dis Colon Rectum       Date:  2007-02       Impact factor: 4.585

6.  Preoperative radiochemotherapy in rectal cancer: long-term results of a phase II trial.

Authors:  J F Bosset; V Magnin; P Maingon; G Mantion; E P Pelissier; M Mercier; G Chaillard; J C Horiot
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-01-15       Impact factor: 7.038

7.  Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01.

Authors:  B Fisher; N Wolmark; H Rockette; C Redmond; M Deutsch; D L Wickerham; E R Fisher; R Caplan; J Jones; H Lerner
Journal:  J Natl Cancer Inst       Date:  1988-03-02       Impact factor: 13.506

8.  Outcomes of clinical T4M0 extra-peritoneal rectal cancer treated with preoperative radiochemotherapy and surgery: a prospective evaluation of a single institutional experience.

Authors:  Vincenzo Valentini; Claudio Coco; Gianluca Rizzo; Alberto Manno; Antonio Crucitti; Claudio Mattana; Carlo Ratto; Alessandro Verbo; Fabio M Vecchio; Brunella Barbaro; Maria A Gambacorta; Caterina Montoro; Maria C Barba; Luigi Sofo; Valerio Papa; Roberta Menghi; Domenico M D'Ugo; Giovanbattista Doglietto
Journal:  Surgery       Date:  2009-03-21       Impact factor: 3.982

9.  Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group.

Authors:  Laurence Collette; Jean-Francois Bosset; Marcel den Dulk; France Nguyen; Laurent Mineur; Philippe Maingon; Ljiljana Radosevic-Jelic; Marianne Piérart; Gilles Calais
Journal:  J Clin Oncol       Date:  2007-10-01       Impact factor: 44.544

10.  Patterns of local recurrence in locally advanced rectal cancer after intra-operative radiotherapy containing multimodality treatment.

Authors:  Miranda Kusters; Fabian A Holman; Hendrik Martijn; Grard A Nieuwenhuijzen; Geert-Jan Creemers; Alette W Daniels-Gooszen; Hetty A van den Berg; Adriaan J van den Brule; Cornelis J H van de Velde; Harm J T Rutten
Journal:  Radiother Oncol       Date:  2009-03-30       Impact factor: 6.280

View more
  6 in total

1.  Chemo-Radiation After Upfront Rectal Resections-a Clinical Dilemma.

Authors:  A Saklani; P Sugoor; M Bhandare; S Jatal; A Desouza; V Ostwal
Journal:  Indian J Surg Oncol       Date:  2018-08-18

2.  Short-Course Radiotherapy versus Long-Course Radio-Chemotherapy as Neoadjuvant Treatment for Locally Advanced Rectal Cancer: Meta-Analysis from a Toxicity Perspective.

Authors:  Horia-Dan Liscu; Andreea-Iuliana Miron; Andra-Raluca Rusea; Ana-Maria Nicoleta Oprea; Ruxandra Mitre; Alexandru Herdea; Razvan Negreanu
Journal:  Maedica (Bucur)       Date:  2021-09

3.  Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer.

Authors:  Wen-Shih Huang; Feng-Che Kuan; Meng-Hung Lin; Miao-Fen Chen; Wen-Cheng Chen
Journal:  Ann Surg Oncol       Date:  2020-08-13       Impact factor: 5.344

4.  Copy number alterations and allelic ratio in relation to recurrence of rectal cancer.

Authors:  Inès J Goossens-Beumer; Jan Oosting; Wim E Corver; Marjolein J F W Janssen; Bart Janssen; Wilbert van Workum; Eliane C M Zeestraten; Cornelis J H van de Velde; Hans Morreau; Peter J K Kuppen; Tom van Wezel
Journal:  BMC Genomics       Date:  2015-06-06       Impact factor: 3.969

5.  Are We Predicting Disease Progress of the Rectal Cancer Patients without Surgery after Neoadjuvant Chemoradiotherapy?

Authors:  Bo Young Oh; Jung Wook Huh; Woo Yong Lee; Yoon Ah Park; Yong Beom Cho; Seong Hyeon Yun; Hee Cheol Kim; Ho-Kyung Chun
Journal:  Cancer Res Treat       Date:  2017-07-03       Impact factor: 4.679

6.  Preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer: Meta-analysis with trial sequential analysis of long-term survival data.

Authors:  Xin Wang; Bobo Zheng; Xinlan Lu; Ruhai Bai; Linlin Feng; Quan Wang; Yan Zhao; Shuixiang He
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.